Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Dr. Lal PathLabs Ltd

LALPATHLAB.NS ✓ COMPLIANT ☆ Track — members

NSE India · Healthcare · Healthcare Facilities & Services ·

India Mid Cap Analyst: BUY

Last Close

$19.80

▲ +0.25%

Market Cap $3.31B · Vol 99.70K

Key Metrics

P/E Ratio

58.47

FWD: 47.99

Market Cap

$3.31B

Mid Cap

Div Yield

0.84%

Quarterly dividend

EPS Growth

+15.55%

YoY

RSI (14)

48.70

Momentum

Beta

0.84

vs Market

52W High

$20.78

5.12% below

52W Low

$13.30

44.96% above

Volume

99.70K

Avg 409.30K

P/B

8.74

Price-to-book

ROE

22.85%

Return on equity

Free Float

45.27%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, Dr. Lal PathLabs Ltd (LALPATHLAB.NS) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does LALPATHLAB.NS pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

-1.15%

+11.42%

+12.70%

+35.08%

YTD

+27.76%

+11.97%

+46.05%

-1.67%

Financials & Valuation

TTM · Annual

Total Revenue	$295.63M
Net Income	$54.54M
Revenue Growth (YoY)	+19.10%
Gross Margin	73.79%
Operating Margin	22.52%
Net Profit Margin	18.45%
ROE	22.85%
ROA · ROIC	22.82% · 20.46%

P/E Ratio	58.47
Forward P/E (FY1)	47.99
PEG Ratio	12.68
P/S	7.94
P/B	8.74
P/FCF	43.36
EPS Growth	+15.55%
Outstanding Shares	167.21M

Technical Indicators

50-Day SMA	$18.45
200-Day SMA	$16.10
RSI (14)	48.70
Beta	0.84
52-Week High	$20.78
52-Week Low	$13.30

Volume Today	99.70K
Avg Daily Volume (30D)	409.30K
Relative Volume	0.24x
Volatility (10D)	19.56
Volatility (30D)	26.44
Free Float	45.27%

Analyst Consensus

BUY

Current Price $19.80

Mean Target $20.36

52W Low$13.30 52W High$20.78

Current

Target

$13.30 $20.78

Current Analyst target

+2.85% upside potential · 25 analysts

Identifiers

ExchangeNSE India

FIGIBBG001SKQ2J9

ISININE600L01024

CountryIndia

Sub-IndustryMedical & Diagnostic Laboratories

Earnings DateOct 29, 2026

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

NTRA Natera Inc +2.21% LH Labcorp Holdings Inc +1.06% RDNT RadNet Inc -0.30% WGS GeneDx Holdings Corp +5.47% NEO Neogenomics Inc +2.72%

Company Profile

Dr. Lal PathLabs Limited is an India-based provider of diagnostic and related healthcare tests and services. The Company is engaged primarily in the business of running laboratories for carrying out pathological investigations in various branches of bio-chemistry, hematology, histopathology, microbiology, electrophoresis, immuno-chemistry, immunology, virology, cytology, and other pathological and radiological investigations. It offers a range of tests, including Pregnancy Test, Full Body Checkups, Covid 19 Test, Heart Test, Kidney Test, Liver Test, Cholesterol Test, Hepatitis B Test, Kidney Function Test, Sugar Test, Thyroid Test, Typhoid Test, Uric Acid Test, Vitamin B12 Test and vitamin D Test. It has approximately 298 clinical laboratories (including National Reference Lab at Delhi, Regional Reference Lab in Kolkata, Bangalore and Mumbai), 6,607 patient service centers, and 12,365 pick-up points (PUPs). Its customers include individual patients, hospitals, and corporate customers.